Europe Transient Protein Expression Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2031 - Regional Analysis - by Product Type (Instruments, Reagents, Expression Vectors, and Competent Cells), Application (Genomic Research, Gene Therapy, Bio production, Cancer Research, and Drug Development), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)

No. of Pages: 153    |    Report Code: TIPRE00022177    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Transient Protein Expression Market

1.           Introduction

1.1       The Insight Partners Research Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Secondary Research

3.2       Primary Research

3.2.1           Hypothesis formulation:

3.2.2           Macro-economic factor analysis:

3.2.3           Developing base number:

3.2.4           Data Triangulation:

3.2.5           Country level data:

4.           Europe Transient Protein Expression Market – Key Market Dynamics

4.1       Market Drivers

4.1.1           Increasing Applications of Protein Expression Systems

4.1.2           Surging Popularity of Precision Medicine

4.2       Market Restraints

4.2.1           High Cost of Products

4.3       Market Opportunities

4.3.1           Plant-Based Expression Systems for Therapeutic Protein Production

4.4       Future Trends

4.4.1           Integration of Artificial Intelligence (AI) and Automation Technologies

4.5       Impact of Drivers and Restraints:

5.           Transient Protein Expression Market – Europe Analysis

5.1       Europe Transient Protein Expression Market Revenue (US$ Million), 2021–2031

5.2       Europe Transient Protein Expression Market Forecast Analysis

6.           Europe Transient Protein Expression Market Analysis – by Product Type

6.1       Instruments

6.1.1           Overview

6.1.2           Instruments: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

6.2       Reagents

6.2.1           Overview

6.2.2           Reagents: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

6.3       Expression Vectors

6.3.1           Overview

6.3.2           Expression Vectors: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

6.4       Competent Cells

6.4.1           Overview

6.4.2           Competent Cells: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

7.           Europe Transient Protein Expression Market Analysis – by Application

7.1       Genomic Research

7.1.1           Overview

7.1.2           Genomic Research: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

7.2       Gene Therapy

7.2.1           Overview

7.2.2           Gene Therapy: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

7.3       Bio production

7.3.1           Overview

7.3.2           Bio production: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

7.4       Cancer Research

7.4.1           Overview

7.4.2           Cancer Research: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

7.5       Drug Development

7.5.1           Overview

7.5.2           Drug Development: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

8.           Europe Transient Protein Expression Market Analysis – by End User

8.1       Pharmaceutical and Biotechnology Companies

8.1.1           Overview

8.1.2           Pharmaceutical and Biotechnology Companies: Europe Transient Protein Expression Market – Revenue and Forecast to 2031  (US$ Million)

8.2       Academic and Research Institutes

8.2.1           Overview

8.2.2           Academic and Research Institutes: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

8.3       Clinical Research Organizations

8.3.1           Overview

8.3.2           Clinical Research Organizations: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

9.           Europe Transient Protein Expression Market – Country Analysis

9.1       Europe

9.1.1           Europe Transient Protein Expression Market Overview

9.1.2           Europe Transient Protein Expression Market – Revenue and Forecast Analysis – by Country

9.1.2.1        Europe Transient Protein Expression Market – Revenue and Forecast Analysis – by Country

9.1.2.2        Germany: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.2.1        Germany: Europe Transient Protein Expression Market Breakdown, by Product Type

9.1.2.2.2        Germany: Europe Transient Protein Expression Market Breakdown, by Application

9.1.2.2.3        Germany: Europe Transient Protein Expression Market Breakdown, by End User

9.1.2.3        United Kingdom: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.3.1        United Kingdom: Europe Transient Protein Expression Market Breakdown, by Product Type

9.1.2.3.2        United Kingdom: Europe Transient Protein Expression Market Breakdown, by Application

9.1.2.3.3        United Kingdom: Europe Transient Protein Expression Market Breakdown, by End User

9.1.2.4        France: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.4.1        France: Europe Transient Protein Expression Market Breakdown, by Product Type

9.1.2.4.2        France: Europe Transient Protein Expression Market Breakdown, by Application

9.1.2.4.3        France: Europe Transient Protein Expression Market Breakdown, by End User

9.1.2.5        Italy: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.5.1        Italy: Europe Transient Protein Expression Market Breakdown, by Product Type

9.1.2.5.2        Italy: Europe Transient Protein Expression Market Breakdown, by Application

9.1.2.5.3        Italy: Europe Transient Protein Expression Market Breakdown, by End User

9.1.2.6        Spain: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.6.1        Spain: Europe Transient Protein Expression Market Breakdown, by Product Type

9.1.2.6.2        Spain: Europe Transient Protein Expression Market Breakdown, by Application

9.1.2.6.3        Spain: Europe Transient Protein Expression Market Breakdown, by End User

9.1.2.7        Rest of Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

9.1.2.7.1        Rest of Europe Transient Protein Expression Market Breakdown, by Product Type

9.1.2.7.2        Rest of Europe Transient Protein Expression Market Breakdown, by Application

9.1.2.7.3        Rest of Europe Transient Protein Expression Market Breakdown, by End User

10.        Competitive Landscape

10.1     Company Positioning & Concentration

11.        Industry Landscape

11.1     Overview

11.2     Growth Strategies in Europe Transient Protein Expression Market

11.3     Organic Growth Strategies

11.3.1         Overview

11.4     Inorganic Growth Strategies

11.4.1         Overview

12.        Company Profiles

12.1     Thermo Fisher Scientific Inc

12.1.1         Key Facts

12.1.2         Business Description

12.1.3         Products and Services

12.1.4         Financial Overview

12.1.5         SWOT Analysis

12.1.6         Key Developments

12.2     Merck KGaA

12.2.1         Key Facts

12.2.2         Business Description

12.2.3         Products and Services

12.2.4         Financial Overview

12.2.5         SWOT Analysis

12.2.6         Key Developments

12.3     QIAGEN NV

12.3.1         Key Facts

12.3.2         Business Description

12.3.3         Products and Services

12.3.4         Financial Overview

12.3.5         SWOT Analysis

12.3.6         Key Developments

12.4     GenScript Biotech Corporation

12.4.1         Key Facts

12.4.2         Business Description

12.4.3         Products and Services

12.4.4         Financial Overview

12.4.5         SWOT Analysis

12.4.6         Key Developments

12.5     Promega Corp

12.5.1         Key Facts

12.5.2         Business Description

12.5.3         Products and Services

12.5.4         Financial Overview

12.5.5         SWOT Analysis

12.5.6         Key Developments

12.6     Takara Bio Inc

12.6.1         Key Facts

12.6.2         Business Description

12.6.3         Products and Services

12.6.4         Financial Overview

12.6.5         SWOT Analysis

12.6.6         Key Developments

12.7     New England Biolabs

12.7.1         Key Facts

12.7.2         Business Description

12.7.3         Products and Services

12.7.4         Financial Overview

12.7.5         SWOT Analysis

12.7.6         Key Developments

12.8     Agilent Technologies Inc

12.8.1         Key Facts

12.8.2         Business Description

12.8.3         Products and Services

12.8.4         Financial Overview

12.8.5         SWOT Analysis

12.8.6         Key Developments

12.9     Mirus Bio LLC

12.9.1         Key Facts

12.9.2         Business Description

12.9.3         Products and Services

12.9.4         Financial Overview

12.9.5         SWOT Analysis

12.9.6         Key Developments

12.10  Bio-Rad Laboratories Inc

12.10.1      Key Facts

12.10.2      Business Description

12.10.3      Products and Services

12.10.4      Financial Overview

12.10.5      SWOT Analysis

12.10.6      Key Developments

12.11  Lonza Group AG

12.11.1      Key Facts

12.11.2      Business Description

12.11.3      Products and Services

12.11.4      Financial Overview

12.11.5      SWOT Analysis

12.11.6      Key Developments

12.12  MaxCyte Inc

12.12.1      Key Facts

12.12.2      Business Description

12.12.3      Products and Services

12.12.4      Financial Overview

12.12.5      SWOT Analysis

12.12.6      Key Developments

13.        Appendix

13.1     About The Insight Partners

13.2     Glossary of Terms

 

 

List of Tables

Table 1.             Europe Transient Protein Expression Market Segmentation

Table 2.             Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Table 3.             Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type

Table 4.             Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million) – by Application

Table 5.             Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million) – by End User

Table 6.             Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Country

Table 7.             Germany: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type

Table 8.             Germany: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 9.             Germany: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 10.          United Kingdom: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type

Table 11.          United Kingdom: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 12.          United Kingdom: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 13.          France: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type

Table 14.          France: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 15.          France: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 16.          Italy: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type

Table 17.          Italy: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 18.          Italy: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 19.          Spain: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type

Table 20.          Spain: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 21.          Spain: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 22.          Rest of Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Product Type

Table 23.          Rest of Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 24.          Rest of Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million) – by End User

Table 25.          Recent Organic Growth Strategies in Europe Transient Protein Expression Market

Table 26.          Recent Inorganic Growth Strategies in the Europe Transient Protein Expression Market

Table 27.          Glossary of Terms, Transiaent Protein Expression Market

 

List of Figures

Figure 1.           Europe Transient Protein Expression Market Segmentation, by Country

Figure 2.           Europe Transient Protein Expression Market – Key Market Dynamics

Figure 3.           Impact Analysis of Drivers and Restraints

Figure 4.           Europe Transient Protein Expression Market Revenue (US$ Million), 2021–2031

Figure 5.           Europe Transient Protein Expression Market Share (%) – by Product Type (2023 and 2031)

Figure 6.           Instruments: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 7.           Reagents: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8.           Expression Vectors: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 9.           Competent Cells: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 10.        Europe Transient Protein Expression Market Share (%) – by Application (2023 and 2031)

Figure 11.        Genomic Research: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 12.        Gene Therapy: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 13.        Bio production: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 14.        Cancer Research: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 15.        Drug Development: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 16.        Europe Transient Protein Expression Market Share (%) – by End User (2023 and 2031)

Figure 17.        Pharmaceutical and Biotechnology Companies: Europe Transient Protein Expression Market – Revenue and Forecast to 2031  (US$ Million)

Figure 18.        Academic and Research Institutes: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 19.        Clinical Research Organizations: Europe Transient Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

Figure 20.        Europe Transient Protein Expression Market Breakdown, by Key Countries - Revenue (2023) (US$ Million)

Figure 21.        Europe Transient Protein Expression Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 22.        Germany: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)

Figure 23.        United Kingdom: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)

Figure 24.        France: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)

Figure 25.        Italy: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)

Figure 26.        Spain: Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)

Figure 27.        Rest of Europe Transient Protein Expression Market – Revenue and Forecast to 2031(US$ Million)

Figure 28.        Company Positioning & Concentration

Figure 29.        Growth Strategies in Europe Transient Protein Expression Market

The List of Companies - Europe Transient Protein Expression Market

  • Thermo Fisher Scientific Inc     
  • Merck KGaA                                      
  • QIAGEN NV                                          
  • GenScript Biotech Corporation     
  • Promega Corp                                     
  • Takara Bio Inc                                     
  • New England Biolabs             
  • Agilent Technologies Inc         
  • Mirus Bio LLC                                
  • Bio-Rad Laboratories Inc          
  • Lonza Group AG
  • MaxCyte Inc